SEC Company Response from InflaRx N.V. (IFRX) (CIK 0001708688) (IFRX) — May 2, 2018
InflaRx N.V. (IFRX) (CIK 0001708688)
Date: May 2, 2018 · CIK: 0001708688 · Accession: 0000950103-18-005709
AI Filing Summary & Sentiment
File numbers found in text: 333-224596
Show Raw Text
CORRESP
1
filename1.htm
May
2, 2018
United
States Securities and Exchange Commission
Division
of Corporate Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Ms. Ada D. Sarmento
Ms. Erin Jaskot
Re:
InflaRx
N.V.
Registration
Statement on Form F-1 (SEC File No. 333-224596)
Dear
Ms. Sarmento and Ms. Jaskot:
In
connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended
(the “Act”), we hereby join in the request of InflaRx N.V. that the effective date of the Registration Statement be
accelerated so that it will be declared effective at 4:00 p.m., Eastern time, on May 3, 2018 or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Act, please be advised that we have distributed 1,020 copies of the Preliminary Prospectus dated May
2, 2018 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and
others.
(Signature
page follows)
J.P.
MORGAN SECURITIES LLC
LEERINK
PARTNERS LLC
BMO
CAPITAL MARKETS CORP.
For
themselves and as representatives of the syndicate of
underwriters
for the offering
J.P.
MORGAN SECURITIES LLC
By:
/s/ David Ke
Authorized Signatory
LEERINK
PARTNERS LLC
By:
/s/ Jack Fitzgerald
Authorized Signatory
BMO
CAPITAL MARKETS CORP.
By:
/s/ Mihir Mantri
Authorized Signatory